Related Experiment Videos

[Cutaneous side effects of EGF-receptor inhibition and their management]

R Gutzmer1, T Werfel, A Kapp

  • 1Klinik und Poliklinik für Dermatologie und Venerologie der Medizinischen Hochschule Hannover. rgutzmer@gmx.de

Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|October 6, 2005
PubMed

Insights

Epidermal growth factor receptor (EGF-receptor) inhibitors used in cancer therapy can cause skin side effects like acneiform lesions, xerosis, and paronychia. This study details these common cutaneous adverse events and their management strategies.

Area of Science:

  • Oncology
  • Dermatology

Background:

  • The epidermal growth factor receptor (EGF-receptor) is implicated in human carcinoma development.
  • Targeting the EGF-receptor with therapies like cetuximab, gefitinib, and erlotinib is a key anti-cancer strategy.
  • EGF-receptor expression in normal skin leads to frequent cutaneous side effects during treatment.

Purpose of the Study:

  • To report on the specific cutaneous side effects associated with EGF-receptor blockade.
  • To discuss the management of these treatment-related skin toxicities.

Main Methods:

  • Review of clinical trial data on EGF-receptor inhibitors.
  • Clinical observation and documentation of skin reactions.

Main Results:

  • Acneiform eruptions are a prominent side effect of EGF-receptor blockade.
  • Xerosis (dry skin) and paronychia (nail inflammation) are also commonly observed.
  • These side effects necessitate specific management approaches.

Conclusions:

  • Cutaneous side effects are common with EGF-receptor inhibitors.
  • Effective management strategies are crucial for patient tolerance and treatment adherence.
  • Understanding and addressing skin toxicities improves patient care in cancer therapy.

Related Concept Videos

Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Renewal of Skin Epidermal Stem Cells01:12

Renewal of Skin Epidermal Stem Cells

The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular cells,...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...